In this episode, experts will explore how blood-based biomarker tests can enable early, accurate Alzheimer’s diagnosis – and what’s needed to develop, standardize, and scale these tests.
...more
View all episodesBy The Global CEO Initiative on Alzheimer's Disease
5
11 ratings
Season 2 Episode 5
In this episode, experts will explore how blood-based biomarker tests can enable early, accurate Alzheimer’s diagnosis – and what’s needed to develop, standardize, and scale these tests.